直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • News
  • Finnegan Facts
  • History
    • Finnegan VISION
    • Finnegan FORWARD
  • Pro Bono
  • Management
    • Pricing & Alternative Fee Arrangements
    • AFA Models We Offer
    • Contingency Fees
    • AI + KM

Commentary

PTAB Wants New Rules to Tackle IPR Imbalance

May 28, 2020

World Intellectual Property Review

On May 26, 2020, the Patent Trial and Appeal Board (PTAB) released proposed changes to the American Invents Act (AIA) trial rules. To address concerns that the current process was discouraging patent owners from filing any testimonial evidence in response to inter partes review (IPR) petitions, the proposed changes would eliminate a presumption in favor of the petitioner on disputes over expert testimony in IPRs. World IP Review contact Finnegan attorney David Reese for his thoughts on the proposed changes.

David said, “Even with adoption of this rule, patent owners may still be hesitant to file testimonial evidence with their preliminary responses because of the lack of pre-institution discovery and for fear that institution under the new rule would make it even more difficult for the patent owner to overcome the institution decision during trial and achieve a favorable final written decision.”

Read the full article here.

Tags

America Invents Act (AIA)

Related Practices

Patent Office Invalidation Proceedings

PTAB Invalidation Proceedings: IPR and PGR

Related Offices

Washington, DC

Related News

Award/Ranking

Forbes Names Finnegan Partner Erika Harmon Arner on its Inaugural 2026 America’s Top Women Lawyers List

June 5, 2026

Award/Ranking

Finnegan Earns Top Rankings in 2026 IAM Patent 1000 Guide; Nearly 60 Attorneys Ranked

May 28, 2026

Commentary

Quince Aims to Have ‘Dupe’ Evidence Shape Ugg Shoe Patent Trial

May 26, 2026

Commentary

New Appellate Opinion in Amazon Biometric Data Case May Signal ‘Narrowing’ Scope of BIPA Litigation, Experts Say

May 20, 2026

Commentary

How Litigation Funding Disclosure Could Affect ITC Cases

May 7 , 2026

Award/Ranking

Associates Rank Finnegan “Best of the Best” in BTI Associate Satisfaction Survey

May 7, 2026

Commentary

Justices to Side with Generic Drugmakers in Patent Spat, Attorneys Predict

May 5, 2026

Commentary

Supreme Court Takes Up Generic Drug Labeling Fight

April 29, 2026

Press Release

Pvtech Secures Stay of New Jersey District Court Litigation Following USPTO Institution of All 10 Ex Parte Reexamination Requests Against Patents Asserted by Jiaxing Super Lighting

April 28, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP